{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T23:57:00Z","timestamp":1792540620408,"version":"4.5.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.ejphar.2021.174112","type":"journal-article","created":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T23:42:56Z","timestamp":1619221376000},"page":"174112","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["Pharmacological evaluation of vanillic acid in rotenone-induced Parkinson's disease rat model"],"prefix":"10.1016","volume":"903","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2786-1874","authenticated-orcid":false,"given":"Neha","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9899-4856","authenticated-orcid":false,"given":"Navneet","family":"Khurana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arunachalam","family":"Muthuraman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puneet","family":"Utreja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.ejphar.2021.174112_bib65","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/81834","article-title":"Chronic systemic pesticide exposure reproduces features of Parkinson\u2019s disease","volume":"3","author":"Betarbet","year":"2000","journal-title":"Nature neuroscience"},{"key":"10.1016\/j.ejphar.2021.174112_bib1","first-page":"82","article-title":"Reduced glutathion estimation","volume":"61","author":"Beutler","year":"1963","journal-title":"J. Lab. Clin. Med. J."},{"key":"10.1016\/j.ejphar.2021.174112_bib2","first-page":"177","article-title":"Parkinson's disease dementia","volume":"363","author":"Bilgi\u00e7","year":"2010","journal-title":"Neuropsychiatr. Cogn. Chang. Park. Dis. Relat. Mov. Disord. Diagnosis Manag."},{"key":"10.1016\/j.ejphar.2021.174112_bib3","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ejphar.2006.09.010","article-title":"Involvement of adenosinergic receptor system in an animal model of tardive dyskinesia and associated behavioural, biochemical and neurochemical changes","volume":"552","author":"Bishnoi","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.174112_bib25","first-page":"32","article-title":"Pharmaceutical Treatment of Parkinson\u2019s Disease","author":"Buyan-Dent","year":"2018","journal-title":"Practical Neurology"},{"key":"10.1016\/j.ejphar.2021.174112_bib4","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1021\/acs.jnatprod.5b00246","article-title":"Vanillic acid inhibits inflammatory pain by inhibiting neutrophil recruitment, oxidative stress, cytokine production, and NF\u03baB activation in mice","volume":"78","author":"Calixto-Campos","year":"2015","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ejphar.2021.174112_bib5","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.nbd.2009.01.016","article-title":"A highly reproducible rotenone model of Parkinson's disease","volume":"34","author":"Cannon","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ejphar.2021.174112_bib6","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1152\/physrev.1979.59.3.527","article-title":"Hydroperoxide metabolism in mammalian organs","volume":"59","author":"Chance","year":"1979","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ejphar.2021.174112_bib7","doi-asserted-by":"crossref","first-page":"9946","DOI":"10.3390\/nu7125514","article-title":"Protective effect of vanillic acid against hyperinsulinemia, hyperglycemia and hyperlipidemia via alleviating hepatic insulin resistance and inflammation in High-Fat Diet (HFD)-fed rats","volume":"7","author":"Chang","year":"2015","journal-title":"Nutrients"},{"key":"10.1016\/j.ejphar.2021.174112_bib8","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/BF00421964","article-title":"On catalepsy and catatonia and the predictability of the catalepsy test for neuroleptic activity","volume":"34","author":"Costall","year":"1974","journal-title":"Psychopharmacologia"},{"key":"10.1016\/j.ejphar.2021.174112_bib9","doi-asserted-by":"crossref","first-page":"19551","DOI":"10.1007\/s11356-016-7168-1","article-title":"The effects of PM10 on electrocardiogram parameters, blood pressure and oxidative stress in healthy rats: the protective effects of vanillic acid","volume":"23","author":"Dianat","year":"2016","journal-title":"Environ. Sci. Pollut. Res."},{"key":"10.1016\/j.ejphar.2021.174112_bib10","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.tins.2005.05.004","article-title":"Mechanisms for selection of basic motor programs - roles for the striatum and pallidum","volume":"28","author":"Grillner","year":"2005","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.ejphar.2021.174112_bib11","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.pneurobio.2018.09.003","article-title":"New insights into the complex role of mitochondria in Parkinson's disease","volume":"177","author":"Gr\u00fcnewald","year":"2019","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.ejphar.2021.174112_bib12","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.ejphar.2016.07.013","article-title":"PASS assisted prediction and pharmacological evaluation of hesperidin against scopolamine induced amnesia in mice","volume":"789","author":"Habibyar","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.174112_bib13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/jcp.26865","article-title":"Oxidative stress and neuroinflammation in the story of Parkinson's disease: could targeting these pathways write a good ending?","volume":"234","author":"Hassanzadeh","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ejphar.2021.174112_bib14","series-title":"Verlag Chemie\/Academic Press Inc.","first-page":"673","article-title":"Catalase","author":"Hugo","year":"1974"},{"key":"10.1016\/j.ejphar.2021.174112_bib15","series-title":"Animal Tissue Techniques","author":"Humason","year":"1962"},{"key":"10.1016\/j.ejphar.2021.174112_bib16","doi-asserted-by":"crossref","first-page":"161S","DOI":"10.1212\/WNL.47.6_Suppl_3.161S","article-title":"Oxidative stress and the pathogenesis of Parkinson \u2019 s disease","volume":"47","author":"Jenner","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.ejphar.2021.174112_bib17","first-page":"1","article-title":"Nonpharmacological modulation of chronic inflammation in Parkinson's disease: role of diet interventions","author":"Kalampokini","year":"2019","journal-title":"Parkinsons. Dis."},{"key":"10.1016\/j.ejphar.2021.174112_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/1279250","article-title":"Approaches and methods to measure oxidative stress in clinical samples: Research applications in the cancer field","volume":"2019","author":"Katerji","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.ejphar.2021.174112_bib19","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.neuro.2013.08.005","article-title":"Ameliorative effect of Sida cordifolia in rotenone induced oxidative stress model of Parkinson's disease","volume":"39","author":"Khurana","year":"2013","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.ejphar.2021.174112_bib20","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ejphar.2011.04.048","article-title":"PASS assisted prediction and pharmacological evaluation of novel nicotinic analogs for nootropic activity in mice","volume":"662","author":"Khurana","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.174112_bib22","series-title":"Handbook of Experimental Pharmacology","author":"Kulkarni","year":"2008"},{"key":"10.1016\/j.ejphar.2021.174112_bib23","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1179\/1351000211Y.0000000009","article-title":"Antihypertensive and antioxidant potential of vanillic acid, a phenolic compound in L-NAME-induced hypertensive rats: a dose-dependence study","volume":"16","author":"Kumar","year":"2011","journal-title":"Redox Rep."},{"issue":"82","key":"10.1016\/j.ejphar.2021.174112_bib64","first-page":"1","article-title":"Protective Effect of Glutathione against Oxidative Stress-induced Cytotoxicity in RAW 264.7 Macrophages through Activating the Nuclear Factor Erythroid 2-Related Factor-2\/Heme Oxygenase-1 Pathway","volume":"8","author":"Kwon","year":"2019","journal-title":"Antioxidants"},{"key":"10.1016\/j.ejphar.2021.174112_bib24","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1006\/abio.1996.9997","article-title":"An isocratic assay for norepinephrine, dopamine, and 5- hydroxytryptamine using their native fluorescence by high-performance liquid chromatography with fluorescence detection in discrete brain areas of rat","volume":"246","author":"Lakshmana","year":"1997","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ejphar.2021.174112_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fncel.2019.00514","article-title":"Pharmacological targeting of microglial activation: new therapeutic approach","volume":"13","author":"Liu","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.ejphar.2021.174112_bib27","doi-asserted-by":"crossref","first-page":"38581","DOI":"10.1074\/jbc.M005385200","article-title":"The Parkinsonism-inducing drug 1-methyl-4-phenylpyridinium triggers intracellular dopamine oxidation: a novel mechanism of toxicity","volume":"275","author":"Lotharius","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2021.174112_bib28","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2021.174112_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-019-0332-6","article-title":"Impaired dopamine metabolism in Parkinson's disease pathogenesis","volume":"14","author":"Masato","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.ejphar.2021.174112_bib32","doi-asserted-by":"crossref","first-page":"432","DOI":"10.4274\/tjps.galenos.2019.92678","article-title":"Safety assessment of vanillic acid: subacute oral toxicity studies in wistar rats","volume":"17","author":"Mirza","year":"2020","journal-title":"Turkish J. Pharm. Sci."},{"key":"10.1016\/j.ejphar.2021.174112_bib33","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1016\/0006-291X(89)91141-8","article-title":"Deficiencies in Complex I subunits of the respiratory chain in Parkinson's disease","volume":"163","author":"Mizuno","year":"1989","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2021.174112_bib58","first-page":"461","article-title":"The role of oxidative stress in Parkinson\u2019s disease","volume":"3","author":"Dias","year":"2013","journal-title":"J Park. Dis"},{"key":"10.1016\/j.ejphar.2021.174112_bib34","first-page":"1","article-title":"The burden of sialorrhoea in chronic neurological conditions: current treatment options and the role of incobotulinumtoxinA (Xeomin\u00ae)","volume":"12","author":"Francesca","year":"2019","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.ejphar.2021.174112_bib35","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0160-5402(83)90028-1","article-title":"Predictive value of muscle relaxant models in rats and cats","volume":"10","author":"Novack","year":"1983","journal-title":"J. Pharmacol. Methods"},{"key":"10.1016\/j.ejphar.2021.174112_bib36","article-title":"Parkinson's disease - a review","volume":"21","author":"Ogun","year":"2002","journal-title":"Afr. J. Neurol. Sci."},{"key":"10.1016\/j.ejphar.2021.174112_bib37","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","article-title":"Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction","volume":"95","author":"Ohkawa","year":"1979","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ejphar.2021.174112_bib38","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.cca.2019.07.037","article-title":"Lipid peroxidation in neurodegeneration","volume":"497","author":"Pe\u00f1a-Bautista","year":"2019","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ejphar.2021.174112_bib39","article-title":"Deficits in cholinergic neurotransmission and their clinical correlates in Parkinson's disease","volume":"2","author":"Perez-Lloret","year":"2016","journal-title":"npj Park. Dis."},{"key":"10.1016\/j.ejphar.2021.174112_bib40","first-page":"229","article-title":"Levodopa in the treatment of Parkinson's disease: an old drug still going strong","volume":"5","author":"Poewe","year":"2010","journal-title":"Clin. Interv. Aging"},{"key":"10.1016\/j.ejphar.2021.174112_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13041-017-0340-9","article-title":"Oxidative stress and cellular pathologies in Parkinson's disease","volume":"10","author":"Puspita","year":"2017","journal-title":"Mol. Brain"},{"key":"10.1016\/j.ejphar.2021.174112_bib42","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/0028-3908(80)90083-0","article-title":"OPIATE-INDUCED muscle rigidity IN the rat: effects OF centrally acting agents","volume":"19","author":"Rackham","year":"1980","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2021.174112_bib43","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0006-8993(98)00419-3","article-title":"Possible role of nitric oxide in the nootropic and antiamnesic effects of neurosteroids on aging- and dizocilpine-induced learning impairment","volume":"799","author":"Reddy","year":"1998","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2021.174112_bib44","first-page":"255","article-title":"Levodopa in the treatment of Parkinson \u2019 s Disease\u00a0: current status and new developments","author":"David","year":"2013","journal-title":"J. Park. Dis."},{"key":"10.1016\/j.ejphar.2021.174112_bib45","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.neuint.2005.12.016","article-title":"L-deprenyl protects against rotenone-induced, oxidative stress-mediated dopaminergic neurodegeneration in rats","volume":"49","author":"Saravanan","year":"2006","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ejphar.2021.174112_bib46","first-page":"273","article-title":"Controversies on new animal models of Parkinson's disease Pro and Con: the rotenone model of Parkinson's disease (PD)","volume":"70","author":"Schmidt","year":"2006","journal-title":"J. Neural. Transm. Suppl."},{"key":"10.1016\/j.ejphar.2021.174112_bib47","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/mds.27602","article-title":"Update on treatments for nonmotor symptoms of Parkinson's disease\u2014an evidence-based medicine review","volume":"34","author":"Seppi","year":"2019","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ejphar.2021.174112_bib48","doi-asserted-by":"crossref","DOI":"10.1007\/s13596-012-0075-1","article-title":"Effect of Cynodon dactylon on rotenone induced Parkinson's disease","volume":"12","author":"Sharma","year":"2012","journal-title":"Orient. Pharm. Exp. Med."},{"key":"10.1016\/j.ejphar.2021.174112_bib49","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.yebeh.2012.11.004","article-title":"Effect of saponin fraction from Ficus religiosa on memory deficit, and behavioral and biochemical impairments in pentylenetetrazol kindled mice","volume":"27","author":"Singh","year":"2013","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.ejphar.2021.174112_bib50","doi-asserted-by":"crossref","first-page":"630","DOI":"10.3109\/13880209.2014.935866","article-title":"Cognitive effects of vanillic acid against streptozotocin-induced neurodegeneration in mice","volume":"53","author":"Singh","year":"2015","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.ejphar.2021.174112_bib31","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.freeradbiomed.2013.05.001","article-title":"Glutathione metabolism and Parkinson\u2019s disease","volume":"62","author":"Smeyne","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejphar.2021.174112_bib51","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s10072-010-0245-1","article-title":"Parkinson's disease: oxidative stress and therapeutic approaches","volume":"31","author":"Surendran","year":"2010","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.ejphar.2021.174112_bib52","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1179\/1476830511Y.0000000033","article-title":"Cellular and molecular mechanisms of antioxidants in Parkinson's disease","volume":"15","author":"Sutachan","year":"2012","journal-title":"Nutr. Neurosci."},{"key":"10.1016\/j.ejphar.2021.174112_bib53","doi-asserted-by":"crossref","first-page":"147","DOI":"10.7150\/ijms.7.147","article-title":"Nitric oxide (NO), citrulline - NO cycle enzymes, glutamine synthetase and oxidative stress in anoxia (hypobaric hypoxia) and reperfusion in rat brain","volume":"7","author":"Swamy","year":"2010","journal-title":"Int. J. Med. Sci."},{"issue":"1\u20133","key":"10.1016\/j.ejphar.2021.174112_bib66","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.tox.2010.03.019","article-title":"A study to correlate rotenone induced biochemical changes and cerebral damage in brain areas with neuromuscular coordination in rats","volume":"272","author":"Swarnkar","year":"2010","journal-title":"Toxicology"},{"key":"10.1016\/j.ejphar.2021.174112_bib54","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1271\/bbb.110700","article-title":"Antioxidative properties of vanillic acid esters in multiple antioxidant assays","volume":"76","author":"Tai","year":"2012","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"10.1016\/j.ejphar.2021.174112_bib55","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1089\/ars.2009.2490","article-title":"Protein misfolding and aggregation in Parkinson's disease","volume":"11","author":"Tan","year":"2009","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.ejphar.2021.174112_bib56","doi-asserted-by":"crossref","first-page":"409","DOI":"10.4103\/0253-7613.161265","article-title":"Evaluation of skeletal muscle relaxant activity of aqueous extract of Nerium oleander flowers in Albino rats","volume":"47","author":"Tirumalasetti","year":"2015","journal-title":"Indian J. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.174112_bib57","first-page":"819","article-title":"Evaluation of vanillic acid analogues as a new class of antifilarial agents","volume":"31","author":"Varma","year":"1993","journal-title":"Indian J. Exp. Biol."},{"key":"10.1016\/j.ejphar.2021.174112_bib59","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.neuint.2009.04.001","article-title":"Effect of centrophenoxine against rotenone-induced oxidative stress in an animal model of Parkinson's disease","volume":"55","author":"Verma","year":"2009","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ejphar.2021.174112_bib60","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1161\/01.RES.82.7.810","article-title":"Superoxide anion from the adventitia of the rat thoracic aorta inactivates nitric oxide","volume":"82","author":"Wang","year":"1998","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2021.174112_bib61","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1345\/aph.1G551","article-title":"Antioxidants, supplements, and Parkinson's disease","volume":"40","author":"Weber","year":"2006","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.ejphar.2021.174112_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnmol.2018.00236","article-title":"Oxidative stress in Parkinson's disease: a systematic review and meta-analysis","volume":"11","author":"Wei","year":"2018","journal-title":"Front. Mol. Neurosci."},{"issue":"2","key":"10.1016\/j.ejphar.2021.174112_bib29","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.expneurol.2008.02.024","article-title":"Enhanced function in the good forelimb of hemi-Parkinson rats: compensatory adaptation for contralateral postural instability?","volume":"211","author":"Woodlee","year":"2008","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ejphar.2021.174112_bib63","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/9426867","article-title":"Benefits of vitamins in the treatment of Parkinson\u2019s disease","volume":"2019","author":"Zhao","year":"2019","journal-title":"Oxid. Med. Cell. Longev."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429992100265X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429992100265X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:49:35Z","timestamp":1757976575000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001429992100265X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":65,"alternative-id":["S001429992100265X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2021.174112","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological evaluation of vanillic acid in rotenone-induced Parkinson's disease rat model","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2021.174112","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"174112"}}